Amanta Healthcare Reports Strong Q2FY27 Results With Operational Expansion
Amanta Healthcare Ltd · Press Release · 04 Nov 2026, 4:58 pm
Amanta Healthcare Reports Strong Q2FY27 Results With Operational Expansion Amanta Healthcare reported a 17.3% YoY revenue rise to ₹83.13 crore in Q2FY27, while EBITDA increased 21.9% YoY to ₹17.95 crore, expanding margins by ~80 bps to 21.6%. PAT jumped to ₹4.86 crore from ₹1.21 crore in Q2FY26. H1FY27 revenue reached ₹151.94 crore with PAT of ₹8.17 crore. The commissioned SteriPort Line 3 expanded capacity by 75% to 11.6 crore bottles, targeting ~₹60 crore FY27 revenue contribution. Further Small Volume Parenteral capacity expansion is targeted for Q1FY28, while a 10.8 MW captive solar plant yields ~₹9 crore annual savings.
Original exchange filing (PDF)
More announcements from Amanta Healthcare Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vishal Ashokkumar Patel · 18 Nov 2026
- submission of Disclosures under Regulation 7(2) of The SEBI (Prohibition of Insider Trading) Regulations, 2015 - off-market transfer of equity shares · 18 Nov 2026
- Company Response On The Spurt In Volume Of Security Across Exchanges · 14 Nov 2026
- The Exchange has sought clarification from Amanta Healthcare Ltd on November 13, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited. · 13 Nov 2026
- Transcript of Post Results Conference call held on November 4, 2026 · 09 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jitendrakumar Jashbhai Patel · 09 Nov 2026
- submission of Disclosure under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 (the "Insider Trading Regulations") · 07 Nov 2026
- submission of Audio Recording of Post Results Conference Call held on November 4, 2026 · 04 Nov 2026
